Healthcare -
Biotechnology - NASDAQ - DK
$ 3.09
-8.04 %
$ 36.3 M
Market Cap
-0.22
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
955.91%
EBIT
Estimate
62.90%
Net Income
Estimate
27.68%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Evaxion Biotech A/S
EVAX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart EVAX
EBIT FORECAST
EBIT Forecast Chart EVAX
NET INCOME FORECAST
Net Income Chart EVAX